Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Neximmune Inc
NEXI
Healthcare
Biotechnology
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML); NEXI-002 in multiple myeloma (MM), and NEXI-003, a solid tumor product candidate for Human...
papillomavirus (HPV) related cancers. The Company provides Artificial Immune Modulation (AIM), which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. The AIM nanoparticles employ signaling proteins to deliver instructions to T cells directing a desired immune response. The Company is also developing new AIM nanoparticle constructs and modalities for clinical evaluation in oncology and autoimmune disorders.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (PINL:NEXI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 2:29pm
NexImmune, Inc. (NASDAQ:NEXI): A Promising Biotech Poised fo
https://beyondspx.com/2024/08/03/neximmune-inc-nasdaqnexi-a-promising-biotech-poised-for-transformation/
(280)
•••
whytestocks
X
Post by
whytestocks
on Feb 06, 2024 9:00pm
NexImmune Announces Closing of $3.67 Million Registered Dire
BREAKING NEWS: $NEXI NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc.
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 06, 2024 4:43pm
New Press Release - NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today...
read article.
(280)
•••
whytestocks
X
Post by
whytestocks
on Feb 02, 2024 6:15pm
NexImmune Announces $3.67 Million Registered Direct Offering
Just In: $NEXI NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology
...more
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 02, 2024 3:11pm
RE:NEXI....hard to keep on top of things....
the previous one was for raising upto 50M, today it is a direct offering where they offered unregistered warrants which will bring the price down because as soon those get exercised, company has to
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 02, 2024 3:10pm
NEXI....hard to keep on top of things....
The 8K is about terminating an old agreement date June 2022 between Cantor and Nexi to raise upto 50 M cash , so the company is not liquidating
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 02, 2024 2:45pm
RE:NEXI....The P.O is terminated
Inline XBRL Viewer (sec.gov)
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 02, 2024 2:43pm
NEXI....The P.O is terminated
WTF
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 02, 2024 2:09pm
RE:NEXI.....please not all at once....Sub $13 now....
Well here it is Flolks ...The Gomer Pyle moment P.O announce...just now Hymen Slimers....LoL Very sneaky
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 02, 2024 2:00pm
New Press Release - NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today...
read article.
(59)
•••
Nibinator
X
Post by
Nibinator
on Jan 30, 2024 5:27pm
MARK
Oh by the way have you remarked what microsoft lended to REMARK
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 30, 2024 3:38pm
NEXI.....please not all at once....Sub $13 now....
as predicted Wait for the announcement It's going to be a "Gomer Pyle" moment ; )
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 30, 2024 3:10pm
NEXI....sub $15...next support is $13
I tell ya...this is going to surprise a whole lot of people Total cr8p
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jan 30, 2024 3:04pm
RE:RE:RE:RE:NEXI.....it all looks rosy right now ...doesn't it!
Sub $16 now...... Excellent !!!!
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jan 30, 2024 2:44pm
RE:RE:RE:NEXI.....it all looks rosy right now ...doesn't it!
sub $17 now..... Isn't this fun
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments